What Utah’s AI industry leaders want you to know
A conversation about the ever-shifting artificial intelligence landscape.
How tourism contributes to Utah’s growth and prosperity
Tracing the economic and cultural impact of Utah’s tourism industry across every season.
How Brad Bonham co-founded Walker Edison
And now advocates for Utah startups as the state’s first entrepreneur-in-residence.
Why Park City Angels invested in Blyncsy
For this month's venture capital spotlight, Doug Wells of Park City Angels writes about investing in Blyncsy.
How David J. Bearss co-founded Halia Therapeutics
And transformed scientific discoveries into life-saving medicines.
How Anna Seear co-founded Ritual Chocolate
And bridged the gap between tradition and taste.
Biolexis secures $10 million in Series A funding to advance metabolic drug development
Biolexis Therapeutics, Inc., a clinical stage AI-driven drug discovery company, announced today the successful closure of a $10 million Series A funding round.